IMMUNOLOGY
Correction for “Squalamine as a broad-spectrum systemic antiviral agent with therapeutic potential,” by Michael Zasloff, A. Paige Adams, Bernard Beckerman, Ann Campbell, Ziying Han, Erik Luijten, Isaura Meza, Justin Julander, Abhijit Mishra, Wei Qu, John M. Taylor, Scott C. Weaver, and Gerard C. L. Wong, which appeared in issue 38, September 20, 2011, of Proc Natl Acad Sci USA (108:15978–15983; first published September 20, 2011; 10.1073/pnas.1108558108).
The authors note that the affiliation for John M. Taylor should instead appear as Fox Chase Cancer Center, Philadelphia, PA 19111. The corrected author and affiliation lines appear below. The online version has been corrected.
Michael Zasloffa,1, A. Paige Adamsb, Bernard Beckermanc, Ann Campbelld, Ziying Hane, Erik Luijtenc,f, Isaura Mezag, Justin Julanderh, Abhijit Mishrai, Wei Quc, John M. Taylore, Scott C. Weaverb, and Gerard C. L. Wongi
aTransplant Institute, Departments of Surgery and Biochemistry and Molecular and Cell Biology, Georgetown University Medical Center, Washington, DC 20007; bInstitute for Human Infections and Immunity and Department of Pathology, University of Texas Medical Branch, Galveston, TX 77555-0609; cDepartment of Materials Science and Engineering, Northwestern University, Evanston, IL 60208-3108; dDepartment of Microbiology and Molecular Cell Biology, Eastern Virginia Medical School, Norfolk, VA 23507; eFox Chase Cancer Center, Philadelphia, PA 19111; fDepartment of Engineering Sciences and Applied Mathematics, Northwestern University, Evanston, IL 60208-3125; gDepartamento de Biomedicina Molecular, Research and Advanced Studies Center of the National Polytechnic Institute of Mexico, 07360 Mexico D.F., Mexico; hInstitute for Antiviral Research, Utah State University, Logan, UT 84322-5600; and iBioengineering Department, Chemistry and Biochemistry Department, California Nano Systems Institute, University of California, Los Angeles, CA 90095-1600